ITUA20163384A1 - RIFAMYCIN DERIVATIVES SV AND THEIR USE FOR THE TREATMENT OF TUBERCULOSIS AND OTHER BACTERIAL INFECTIONS. - Google Patents

RIFAMYCIN DERIVATIVES SV AND THEIR USE FOR THE TREATMENT OF TUBERCULOSIS AND OTHER BACTERIAL INFECTIONS.

Info

Publication number
ITUA20163384A1
ITUA20163384A1 ITUA2016A003384A ITUA20163384A ITUA20163384A1 IT UA20163384 A1 ITUA20163384 A1 IT UA20163384A1 IT UA2016A003384 A ITUA2016A003384 A IT UA2016A003384A IT UA20163384 A ITUA20163384 A IT UA20163384A IT UA20163384 A1 ITUA20163384 A1 IT UA20163384A1
Authority
IT
Italy
Prior art keywords
tuberculosis
treatment
bacterial infections
rifamycin derivatives
rifamycin
Prior art date
Application number
ITUA2016A003384A
Other languages
Italian (it)
Inventor
Mario Brufani
Rocco Figliola
Bella Angela La
Francesca Leonelli
Bettolo Rinaldo Marini
Rolando Marzella
Luisa Maria Migneco
Alessio Sferrazza
Azzurra Stefanucci
Original Assignee
Istituto Biochimico Naz Savio Srl
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Istituto Biochimico Naz Savio Srl filed Critical Istituto Biochimico Naz Savio Srl
Priority to ITUA2016A003384A priority Critical patent/ITUA20163384A1/en
Publication of ITUA20163384A1 publication Critical patent/ITUA20163384A1/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D498/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D498/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
    • C07D498/08—Bridged systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D498/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D498/12—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms in which the condensed system contains three hetero rings
    • C07D498/18—Bridged systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
ITUA2016A003384A 2016-05-12 2016-05-12 RIFAMYCIN DERIVATIVES SV AND THEIR USE FOR THE TREATMENT OF TUBERCULOSIS AND OTHER BACTERIAL INFECTIONS. ITUA20163384A1 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
ITUA2016A003384A ITUA20163384A1 (en) 2016-05-12 2016-05-12 RIFAMYCIN DERIVATIVES SV AND THEIR USE FOR THE TREATMENT OF TUBERCULOSIS AND OTHER BACTERIAL INFECTIONS.

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
ITUA2016A003384A ITUA20163384A1 (en) 2016-05-12 2016-05-12 RIFAMYCIN DERIVATIVES SV AND THEIR USE FOR THE TREATMENT OF TUBERCULOSIS AND OTHER BACTERIAL INFECTIONS.

Publications (1)

Publication Number Publication Date
ITUA20163384A1 true ITUA20163384A1 (en) 2017-11-12

Family

ID=56940159

Family Applications (1)

Application Number Title Priority Date Filing Date
ITUA2016A003384A ITUA20163384A1 (en) 2016-05-12 2016-05-12 RIFAMYCIN DERIVATIVES SV AND THEIR USE FOR THE TREATMENT OF TUBERCULOSIS AND OTHER BACTERIAL INFECTIONS.

Country Status (1)

Country Link
IT (1) ITUA20163384A1 (en)

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3817986A (en) * 1972-03-27 1974-06-18 Lepetit Spa Pyrono-rifamycins
WO2009010555A1 (en) * 2007-07-17 2009-01-22 Segix Italia S.R.L. New drugs with anticholestatic activity

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3817986A (en) * 1972-03-27 1974-06-18 Lepetit Spa Pyrono-rifamycins
WO2009010555A1 (en) * 2007-07-17 2009-01-22 Segix Italia S.R.L. New drugs with anticholestatic activity

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
CRICCHIO R ET AL: "HYDRAZONES OF 3-FORMYLRIFAMYCIN SV PART I - HYDRAZONES WITH N-AMINO-N'SUBSTITUTED PIPERAZINES: SYNTHESIS, ANTIBACTERIAL ACTIVITY AND OTHER BIOLOGICAL PROPERTIES", IL FARMACO, ELSEVIER FRANCE * EDITIONS SCIENTIFIQUES ET MEDICALES, FR, vol. 30, no. 8, August 1975 (1975-08-01), pages 605 - 619, XP001005614, ISSN: 0014-827X *

Similar Documents

Publication Publication Date Title
CO2018008761A2 (en) Maitansinoid derivatives, conjugates of the same methods of use
CL2018000813A1 (en) Antibody-pyrrolobenzodiazepine drug conjugates and methods of use.
CO2017010890A2 (en) Maytansinoid derivatives, conjugates thereof, and methods of use
CL2018000978A1 (en) Peptide macrocycles against acinetobacter baumannii
IT201700101704A1 (en) NEW USE FOR TREATMENT OF DIFFICULT CLOSTRIDIUM INFECTIONS
CL2016002735A1 (en) Imidazo [4,5-c] quinolin-2-one compounds and their use to treat cancer
CR20180013A (en) ANTI-TAU ANTIBODIES AND METHODS OF USE.
CL2018003444A1 (en) Adenosine derivatives for use in the treatment of cancer.
CL2015002658A1 (en) Derivatives of 2,3-disubstitute 1- acyl-4-amino-1,2,3,4-tetrahydroquiniline and its use as bromodomain inhibitors
BR112016020199A2 (en) Human plasma kallikrein inhibitor compound, pharmaceutical composition comprising said compound, kit and its use
CL2018001171A1 (en) Imidazo [4,5-c] quinolin-2-one compounds and their use in cancer treatment
CL2015003686A1 (en) Pyrrolo [3,2-d] pyrimidine derivatives for the treatment of viral infections and other diseases
CL2016002495A1 (en) Macrocyclic pyridine derivatives.
BR112016030787A2 (en) chemical entity, pharmaceutical composition and its use
MX2017007055A (en) Anti-staphylococcus aureus antibody rifamycin conjugates and uses thereof.
CL2015003019A1 (en) Biaromatic antibacterial derivatives
CL2018000565A1 (en) Compounds derived from pyridinone dicarboxamide, bromodomain inhibitors; pharmaceutical composition; pharmaceutical combination; Useful in the treatment of autoimmune, inflammatory, viral and cancer diseases, among others.
DK3606928T3 (en) MACROCYCLIC COMPOUND AND USES THEREOF
CL2016001937A1 (en) Functionalized benzopyran compounds and their use
CL2016002151A1 (en) Pyridazine derivatives for use in the prevention or treatment of an ataxic disorder
CL2019000049A1 (en) Processes for the preparation of 4-alkoxy - (acyl or aquyl) oxy-picolinamide.
CL2018003417A1 (en) New compounds
DK3509598T3 (en) NEW USE OF TRIAZOLO (4,5-D) PYRIMIDINE DERIVATIVES FOR THE PREVENTION AND TREATMENT OF BACTERIAL INFECTION
CL2015002113A1 (en) Azetidinloxyphenylpyrrolidine compounds
UY36117A (en) PHARMACEUTICAL COMPOSITIONS FOR THE TREATMENT OF INFECTIOUS DISEASES.